{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:55:32Z","timestamp":1776873332076,"version":"3.51.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022CR09"],"award-info":[{"award-number":["2022CR09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03732-6","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T13:02:38Z","timestamp":1725022958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sunitinib-induced endocapillary proliferative glomerulonephritis with IgA2 deposit in addition to thrombotic microangiopathy: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fude","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"issue":"1","key":"3732_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13045-020-01026-6","volume":"14","author":"CM Kelly","year":"2021","unstructured":"Kelly CM, Gutierrez Sainz L, Chi P. The management of metastatic GIST: current standard and investigational therapeutics. J Hematol Oncol. 2021;14(1):2. https:\/\/doi.org\/10.1186\/s13045-020-01026-6. Published 2021 Jan 5.","journal-title":"J Hematol Oncol."},{"issue":"5","key":"3732_CR2","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/cvr\/cvz022","volume":"115","author":"J Versmissen","year":"2019","unstructured":"Versmissen J, Mirabito Colafella KM, et al. Vascular Cardio-Oncology: vascular endothelial growth factor inhibitors and hypertension. Cardiovasc Res. 2019;115(5):904\u201314. https:\/\/doi.org\/10.1093\/cvr\/cvz022.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"3732_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/his.13716","volume":"73","author":"F Pfister","year":"2018","unstructured":"Pfister F, Amann K, Daniel C, et al. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy. Histopathology. 2018;73(6):990\u20131001. https:\/\/doi.org\/10.1111\/his.13716.","journal-title":"Histopathology"},{"issue":"3","key":"3732_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/ndt\/gfp666","volume":"25","author":"O Costero","year":"2010","unstructured":"Costero O, Picazo ML, Zamora P, et al. Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy. Nephrol Dial Transpl. 2010;25(3):1001\u20133. https:\/\/doi.org\/10.1093\/ndt\/gfp666.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"3732_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/ndt\/gft465","volume":"29","author":"C Vigneau","year":"2014","unstructured":"Vigneau C, Lorcy N, Dolley-Hitze T, et al. All anti-vascular endothelial growth factor drugs can induce \u2018pre-eclampsia-like syndrome\u2019: a RARe study. Nephrol Dial Transpl. 2014;29(2):325\u201332. https:\/\/doi.org\/10.1093\/ndt\/gft465.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"3732_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ki.2008.288","volume":"74","author":"JS Obhrai","year":"2008","unstructured":"Obhrai JS, Patel TV, Humphreys BD. The case \/ progressive hypertension and proteinuria on anti-angiogenic therapy. Kidney Int. 2008;74(5):685\u20136. https:\/\/doi.org\/10.1038\/ki.2008.288.","journal-title":"Kidney Int"},{"issue":"11","key":"3732_CR7","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358(11):1129\u201336. https:\/\/doi.org\/10.1056\/NEJMoa0707330.","journal-title":"N Engl J Med"},{"issue":"8","key":"3732_CR8","doi-asserted-by":"publisher","first-page":"e243567","DOI":"10.1136\/bcr-2021-243567","volume":"14","author":"S Zonoozi","year":"2021","unstructured":"Zonoozi S, Palmer M, Ursina T, et al. Worsening membranous nephropathy in a patient with GIST treated with sunitinib. BMJ Case Rep. 2021;14(8):e243567. https:\/\/doi.org\/10.1136\/bcr-2021-243567. Published 2021 Aug 11.","journal-title":"BMJ Case Rep"},{"issue":"4","key":"3732_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10456-006-9055-8","volume":"9","author":"M Shibuya","year":"2006","unstructured":"Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1\/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9(4):225\u201331. https:\/\/doi.org\/10.1007\/s10456-006-9055-8.","journal-title":"Angiogenesis"},{"key":"3732_CR10","doi-asserted-by":"publisher","first-page":"1168635","DOI":"10.3389\/fimmu.2023.1168635","volume":"14","author":"A Domokos","year":"2023","unstructured":"Domokos A, Varga Z, Jambrovics K, et al. The transcriptional control of the VEGFA-VEGFR1 (FLT1) axis in alternatively polarized murine and human macrophages. Front Immunol. 2023;14:1168635. https:\/\/doi.org\/10.3389\/fimmu.2023.1168635. Published 2023 May 4.","journal-title":"Front Immunol"},{"issue":"3","key":"3732_CR11","doi-asserted-by":"publisher","first-page":"105961","DOI":"10.1016\/j.isci.2023.105961","volume":"26","author":"X Chen","year":"2023","unstructured":"Chen X, Li M, Zhu S, et al. Proteomic profiling of IgA nephropathy reveals distinct molecular prognostic subtypes. iScience. 2023;26(3):105961. https:\/\/doi.org\/10.1016\/j.isci.2023.105961.\u00a0Published 2023 Jan 13.","journal-title":"iScience."},{"issue":"5","key":"3732_CR12","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/ndt\/gfi292","volume":"21","author":"Y Arakawa","year":"2006","unstructured":"Arakawa Y, Shimizu Y, Sakurai H, et al. Polyclonal activation of an IgA subclass against Staphylococcus aureus cell membrane antigen in post-methicillin-resistant S. aureus infection glomerulonephritis. Nephrol Dial Transpl. 2006;21(5):1448\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfi292.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"3732_CR13","doi-asserted-by":"publisher","first-page":"R230","DOI":"10.1152\/ajpregu.00373.2015","volume":"310","author":"S Lankhorst","year":"2016","unstructured":"Lankhorst S, van den Danser AH. Endothelin-1 and antiangiogenesis. Am J Physiol Regul Integr Comp Physiol. 2016;310(3):R230\u20134. https:\/\/doi.org\/10.1152\/ajpregu.00373.2015.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"3732_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/HYPERTENSIONAHA.115.05435","volume":"66","author":"S Lankhorst","year":"2015","unstructured":"Lankhorst S, Baelde HJ, Kappers MH, et al. Greater sensitivity of blood pressure than renal toxicity to tyrosine kinase receptor inhibition with Sunitinib. Hypertension. 2015;66(3):543\u20139. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05435.","journal-title":"Hypertension"},{"issue":"4","key":"3732_CR15","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/ijms24043427","volume":"24","author":"I Mart\u00ednez-D\u00edaz","year":"2023","unstructured":"Mart\u00ednez-D\u00edaz I, Martos N, Llorens-Cebri\u00e0 C, et al. Endothelin receptor antagonists in kidney disease. Int J Mol Sci. 2023;24(4):3427. https:\/\/doi.org\/10.3390\/ijms24043427. Published 2023 Feb 8.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3732_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/HYPERTENSIONAHA.110.155762","volume":"56","author":"N Dhaun","year":"2010","unstructured":"Dhaun N, Webb DJ. Receptor tyrosine kinase inhibition, hypertension, and proteinuria: is endothelin the smoking gun? Hypertension. 2010;56(4):575\u20137. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.155762.","journal-title":"Hypertension"},{"issue":"2","key":"3732_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","volume":"46","author":"H Izzedine","year":"2010","unstructured":"Izzedine H, Massard C, Spano JP, et al. VEGF signalling inhibition-induced proteinuria: mechanisms, significance and management. Eur J Cancer. 2010;46(2):439\u201348. https:\/\/doi.org\/10.1016\/j.ejca.2009.11.001.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3732_CR18","doi-asserted-by":"publisher","first-page":"e028050","DOI":"10.1161\/JAHA.122.028050","volume":"12","author":"DCH van Dorst","year":"2023","unstructured":"van Dorst DCH, Kabadayi S, Oomen-de Hoop E, et al. Treatment and implications of vascular endothelial growth factor inhibitor-Induced blood pressure rise: a clinical cohort study. J Am Heart Assoc. 2023;12(1):e028050. https:\/\/doi.org\/10.1161\/JAHA.122.028050.","journal-title":"J Am Heart Assoc"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03732-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T13:04:21Z","timestamp":1725023061000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03732-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3732"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03732-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Peking University First Hospital (2017[1280]). The authors declare that they have obtained consent from the patient reported in this article for publication of the information about him that appears within this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained in both written and verbal format from the patient to publish this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"284"}}